AttendMe Owl Logo
AttendMe
Evidence Evolution
Evidence Evolution
Landmark TrialCohort Study

Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy

Annals of Surgery2004IF: 4.0

René Adam, V. Delvart, Gérard Pascal, Adrian Valeanu, Denis Castaing, Daniel Azoulay, Sylvie Giacchetti, Bernard Paule, F Kunstlinger, O Ghémard, Françis Lévi, Henri Bismuth

PMID: 15383792View on PubMedDOI

Abstract

Modern chemotherapy allows 12.5% of patients with unresectable CRLM to be rescued by liver surgery. Despite a high rate of recurrence, 5-year survival is 33% overall, with a wide use of repeat hepatectomies and extrahepatic resections. Four preoperative risk factors could select the patients most likely to benefit from this strategy.

Specialty

Hepatobiliary Surgery

Featured in Evidence Evolutions